Ole Audun Werner Haabeth

Cancer Institute (WIA) — India

Immunology and Microbiology · Life Sciences

21h-index2.4kcitations82works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(44), Immune Cell Function and Interaction(30), CAR-T cell therapy research(25), RNA Interference and Gene Delivery(20), Cancer Immunotherapy and Biomarkers(18)

Publications81 total

937 Structural optimization of multi-epitope mRNA constructs enhances MHC class II presentation and reduces immune interference in personalized cancer vaccines
Regular and Young Investigator Award Abstracts·2025Open Access
1188 Nutshell® nanoparticles containing engineered degradable peptoids are safe and effective formulations for mRNA-based personalized cancer therapeutics
Regular and Young Investigator Award Abstracts·2025Open Access
<i>In Vivo</i> mRNA Delivery to the Lung Vascular Endothelium by Dicationic Charge-Altering Releasable Transporters
Journal of the American Chemical Society·2025· 2 cited
NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability
2025Open Access
Nanoparticle-formulated mRNA encoding engineered multivalent SIRPα-Fc fusion proteins shows robust anti-cancer activity in preclinical models
Molecular Therapy — Nucleic Acids·2025Open Access
<i>In vivo</i> mRNA delivery to the lung vascular endothelium by dicationic Charge-Altering Releasable Transporters
2025Open Access
Discovery of a Peptoid-Based Nanoparticle Platform for Therapeutic mRNA Delivery via Diverse Library Clustering and Structural Parametrization
ACS Nano·2024· 9 citedOpen Access
Development of NTX-472, a formulated mRNA therapy targeting CD20, CD19, and CD47, for treatment of B-cell lymphoma.
Journal of Clinical Oncology·2024· 1 cited
Abstract 6725: NTX-470, a novel multispecific T cell engager expressed from mRNA targets PSMA and STEAP1 prostate cancer antigens to generate enhanced functional activity
Cancer Research·2024
Abstract 6536: Enhanced membrane stability of mRNA nanoparticle derived TNFSF14 results in superior T-cell and NK cell stimulation
Cancer Research·2024
1359 NTX-0471, engineered multivalent SIRPa and bispecific SIRPa-antiCCR4 molecules demonstrate superior activity providing path for mRNA expressed <i>in-vivo</i> biologics
Regular and Young Investigator Award Abstracts·2023Open Access
Abstract LB346: Mapping of shared tumor antigen reactivity with nanoparticle encapsulated mRNA in prostate cancer patients
Cancer Research·2023
Abstract 690: Modification of mRNA-encoded HPV16 antigens to include endolysosomal trafficking domains drives cross-presentation and results in superior <i>in vivo</i> and <i>ex vivo</i> antigen-specific responses
Cancer Research·2023
Abstract 5163: Local delivery of mRNA immunotherapy encoding HPV16 antigen, IL-12, and LIGHT/TNFSF14 results in superior immunogenicity and tumor clearance in a murine model of HPV16-driven cancer
Cancer Research·2023
Data from Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an &lt;i&gt;In Situ&lt;/i&gt; Inflammatory Immune Response
2023Open Access
Supplementary Table S1 from Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an &lt;i&gt;In Situ&lt;/i&gt; Inflammatory Immune Response
2023Open Access
Supplementary figure S3 from CD4&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
2023Open Access
Supplementary figure S1 from CD4&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
2023Open Access
Data from CD4&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
2023Open Access
Supplementary figure S1 from CD4&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Bjarne Bogen(25), Anders Tveita(21), Alexandre Corthay(18), Marte Fauskanger(18), Ronald Levy(13), Robert M. Waymouth(12), Paul A. Wender(12), Kristina Berg Lorvik(10), Adrienne Sallets(9), Guttorm Haraldsen(8), Colin J. McKinlay(8), Timothy R. Blake(8), Clara Hammarström(7), Debra K. Czerwinski(7), Melanie Manzke(6), Katrin U. Lundin(6), Fredrik Schjesvold(5), Michael Zangani(5), Nancy L. Benner(4), Bjarne Bogen(4)